Three open positions are currently available at the University of Southampton, as part of a Medical Research Council – Developmental Pathway Funding Scheme (MRC-DPFS) grant 2023 for research into asthma with the title: “Preclinical efficacy and safety studies of ADAM33 oligonucleotides as new disease-modifying asthma therapy.” under the supervision of the award holders and principle investigators Dr Hans Michael Haitchi (University of Southampton (UoS)) & Professor Jonathan K. Watts (Institute for RNA Therapeutics, University of Massachusetts (UMass), USA).
top of page
bottom of page